Bellicum Pharmaceuticals, Inc. (BLCM)
Total Valuation
BLCM has a market cap or net worth of $2.43 million. The enterprise value is -$3.48 million.
| Market Cap | 2.43M |
| Enterprise Value | -3.48M |
Important Dates
The last earnings date was Tuesday, August 29, 2023, after market close.
| Earnings Date | Aug 29, 2023 |
| Ex-Dividend Date | n/a |
Share Statistics
BLCM has 9.72 million shares outstanding. The number of shares has increased by 0.24% in one year.
| Shares Outstanding | 9.72M |
| Shares Change (YoY) | +0.24% |
| Shares Change (QoQ) | +0.23% |
| Owned by Insiders (%) | 1.23% |
| Owned by Institutions (%) | 25.05% |
| Float | 6.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.61 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.04
| Current Ratio | 3.04 |
| Quick Ratio | 2.63 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | 45.10 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -318.07% |
| Return on Capital (ROIC) | n/a |
| Revenue Per Employee | $116,000 |
| Profits Per Employee | -$1.68M |
| Employee Count | 13 |
| Asset Turnover | 0.17 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -295,998 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -81.73% in the last 52 weeks. The beta is 1.36, so BLCM's price volatility has been higher than the market average.
| Beta (1Y) | 1.36 |
| 52-Week Price Change | -81.73% |
| 50-Day Moving Average | 0.23 |
| 200-Day Moving Average | 0.44 |
| Relative Strength Index (RSI) | 56.36 |
| Average Volume (30 Days) | 17,065 |
Short Selling Information
The latest short interest is 1.44 million, so 14.81% of the outstanding shares have been sold short.
| Short Interest | 1.44M |
| Short Previous Month | 527,201 |
| Short % of Shares Out | 14.81% |
| Short % of Float | 22.92% |
| Short Ratio (days to cover) | 0.17 |
Income Statement
In the last 12 months, BLCM had revenue of $1.51 million and -$21.80 million in losses. Loss per share was -$1.58.
| Revenue | 1.51M |
| Gross Profit | 1.51M |
| Operating Income | -23.05M |
| Pretax Income | -22.38M |
| Net Income | -21.80M |
| EBITDA | -25.33M |
| EBIT | -25.34M |
| Loss Per Share | -$1.58 |
Balance Sheet
The company has $5.91 million in cash and no debt, giving a net cash position of $5.91 million or $0.61 per share.
| Cash & Cash Equivalents | 5.91M |
| Total Debt | n/a |
| Net Cash | 5.91M |
| Net Cash Per Share | $0.61 |
| Equity / Book Value | -27.01M |
| Book Value Per Share | -2.78 |
| Working Capital | 4.60M |
Cash Flow
In the last 12 months, operating cash flow was -$22.85 million and capital expenditures -$11,000, giving a free cash flow of -$22.86 million.
| Operating Cash Flow | -22.85M |
| Capital Expenditures | -11,000 |
| Free Cash Flow | -22.86M |
| FCF Per Share | -$0.74 |
Margins
Gross margin is 100.00%, with operating and profit margins of -1,528.71% and -1,445.42%.
| Gross Margin | 100.00% |
| Operating Margin | -1,528.71% |
| Pretax Margin | -1,483.82% |
| Profit Margin | -1,445.42% |
| EBITDA Margin | -1,679.97% |
| EBIT Margin | -1,680.57% |
| FCF Margin | -1,515.98% |
Dividends & Yields
BLCM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -897.28% |
| FCF Yield | -941.08% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.24% |
| Shareholder Yield | -0.24% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on February 6, 2020. It was a reverse split with a ratio of 1:10.
| Last Split Date | Feb 6, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
BLCM has an Altman Z-Score of -131.99 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -131.99 |
| Piotroski F-Score | 1 |